Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vigil Neuroscience, Inc. - Common Stock (NQ:VIGL)

7.895 +0.015 (+0.19%)
Streaming Delayed Price Updated: 3:20 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vigil Neuroscience, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Which stocks have an unusual volume on Friday?
Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert
U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in premarket. 
Via Benzinga
Nasdaq Gains Over 50 Points Following Positive Economic Reports: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Vigil Neuroscience: Q4 Earnings Insights
Via Benzinga
Dow Moves Higher; US Initial Jobless Claims Fall
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views
Via Benzinga
Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying
The company is working on an Alzheimer's treatment that increases the activity of TREM2, a neuroinflammation target. 
Via Investor's Business Daily
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish
Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing. 
Via Stocktwits
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition
Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition excludes monoclonal antibody program and is expected to be finalized in Q3... 
Via Benzinga
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
These stocks have an unusual volume in today's session 
Via Chartmill
Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3
Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q2 2024
VIGL stock results show that Vigil Neuroscience beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Small Neurodegenerative Disease-Focused Vigil Neuroscience Says Alzheimer's Candidate Shows Significant Impact On Disease Bimarker
Vigil Neuroscience reports promising interim results from its Phase 1 trial of VG-3927, showing a strong safety, tolerability, and pharmacokinetic profile in healthy volunteers. The data support... 
Via Benzinga
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
Tonix Pharmaceuticals stock is falling on Thursday after the company announced a proposed public offering for shares of TNXP. 
Via InvestorPlace
Why Is Branchout Food (BOF) Stock Down 39% Today?
Branchout Food stock is down on Thursday after the company priced an offering of 1.75 million shares of BOF at 80 cents each. 
Via InvestorPlace
Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?
Vigil Neuroscience stock is up with heavy trading of VIGL shares this morning on news of a $40 million investment from Sanofi. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
3 Penny Stocks With the Power to 10X Your $1k Investment: June Edition
Penny stocks are risky because of their insane volatility — but these have a chance to 10x your investments. 
Via InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q1 2024
VIGL stock results show that Vigil Neuroscience beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
VIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023
VIGL stock results show that Vigil Neuroscience missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.